Enzo Biochem, Inc. (ENZB)
ENZB Stock Price Chart
Explore Enzo Biochem, Inc. interactive price chart. Choose custom timeframes to analyze ENZB price movements and trends.
ENZB Company Profile
Discover essential business fundamentals and corporate details for Enzo Biochem, Inc. (ENZB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
12 Jun 1980
Employees
125.00
Website
https://www.enzo.comCEO
Kara Cannon
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.
ENZB Financial Timeline
Browse a chronological timeline of Enzo Biochem, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 15 Dec 2025
Upcoming earnings on 27 Oct 2025
Earnings released on 16 Jun 2025
EPS came in at -$0.04 , while revenue for the quarter reached $6.40M .
Earnings released on 17 Mar 2025
EPS came in at -$0.02 , while revenue for the quarter reached $7.33M .
Earnings released on 16 Dec 2024
EPS came in at -$0.05 , while revenue for the quarter reached $6.21M .
Earnings released on 29 Oct 2024
EPS came in at -$0.26 , while revenue for the quarter reached $7.53M .
Dividend declared on 29 Oct 2024
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 2 Dec 2024.
Earnings released on 13 Jun 2024
EPS came in at -$0.03 , while revenue for the quarter reached $8.02M .
Earnings released on 13 Mar 2024
EPS came in at -$0.06 , while revenue for the quarter reached $8.55M .
Earnings released on 15 Dec 2023
EPS came in at -$0.11 , while revenue for the quarter reached $7.81M .
Earnings released on 27 Oct 2023
EPS came in at -$0.17 , while revenue for the quarter reached -$19.66M .
Earnings released on 14 Jun 2023
EPS came in at -$0.31 , while revenue for the quarter reached $16.11M .
Earnings released on 20 Mar 2023
EPS came in at -$0.23 , while revenue for the quarter reached $16.34M .
Earnings released on 12 Dec 2022
EPS came in at -$0.18 , while revenue for the quarter reached $18.28M .
Earnings released on 14 Oct 2022
EPS came in at -$0.17 , while revenue for the quarter reached $20.28M .
Earnings released on 9 Jun 2022
EPS came in at -$0.09 , while revenue for the quarter reached $26.22M .
Earnings released on 14 Mar 2022
EPS came in at $0.03 , while revenue for the quarter reached $34.05M .
Earnings released on 15 Dec 2021
EPS came in at -$0.04 , while revenue for the quarter reached $26.52M .
Earnings released on 12 Oct 2021
EPS came in at $0.07 , while revenue for the quarter reached $24.81M .
Earnings released on 9 Jun 2021
EPS came in at $0.04 , while revenue for the quarter reached $32.80M .
Earnings released on 15 Mar 2021
EPS came in at $0.09 , while revenue for the quarter reached $31.47M .
Earnings released on 9 Dec 2020
EPS came in at $0.01 , while revenue for the quarter reached $28.66M .
Earnings released on 13 Oct 2020
EPS came in at -$0.07 , while revenue for the quarter reached $19.53M .
ENZB Stock Performance
Access detailed ENZB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.